Pérez-Domper, P., Palomo, V., Gradari, S., Gil, C., de Ceballos, M. L., Martínez, A., & Trejo, J. L. (2017). The GSK-3-inhibitor VP2.51 produces antidepressant effects associated with adult hippocampal neurogenesis. Neuropharmacology, 116, 174. https://doi.org/10.1016/j.neuropharm.2016.12.019
Chicago Style (17th ed.) CitationPérez-Domper, Paloma, Valle Palomo, Simona Gradari, Carmen Gil, María L. de Ceballos, Ana Martínez, and Jose Luis Trejo. "The GSK-3-inhibitor VP2.51 Produces Antidepressant Effects Associated with Adult Hippocampal Neurogenesis." Neuropharmacology 116 (2017): 174. https://doi.org/10.1016/j.neuropharm.2016.12.019.
MLA (9th ed.) CitationPérez-Domper, Paloma, et al. "The GSK-3-inhibitor VP2.51 Produces Antidepressant Effects Associated with Adult Hippocampal Neurogenesis." Neuropharmacology, vol. 116, 2017, p. 174, https://doi.org/10.1016/j.neuropharm.2016.12.019.